AB SICAV I-International Health Care Pf S1 EUR (LU0260062871)
203.53
-1.01
(-0.49%)
EUR |
May 15 2026
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| -- | -- | -- | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -- | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Broad Asset Class | None |
| Broad Category | None |
| Global Peer Group | None |
| Peer Group | None |
| Global Macro | None |
| US Macro | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | None |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
--
Peer Group Low
--
Peer Group High
1 Year
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
6 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
5 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
YTD
% Rank:
--
--
Peer Group Low
--
Peer Group High
10 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 16, 2026.
Asset Allocation
| Type | % Net |
|---|
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Johnson & Johnson | 9.86% | 226.71 | -1.77% |
| Eli Lilly & Co. | 9.09% | 1004.92 | -0.18% |
| Novartis AG | 6.04% | 142.65 | -2.12% |
| AstraZeneca PLC | 6.01% | 181.58 | -1.83% |
| Roche Holding AG | 5.35% | 407.16 | 3.29% |
| Gilead Sciences, Inc. | 4.49% | 129.58 | -1.88% |
| AbbVie, Inc. | 4.26% | 210.39 | -0.18% |
| UnitedHealth Group, Inc. | 3.94% | 393.85 | -1.31% |
| Intuitive Surgical, Inc. | 3.57% | 421.12 | -1.62% |
| Stryker Corp. | 3.57% | 306.76 | 0.41% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors | -- |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Broad Asset Class | None |
| Broad Category | None |
| Global Peer Group | None |
| Peer Group | None |
| Global Macro | None |
| US Macro | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | None |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM | -- |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| ROI (TTM) | -- |
| Return on Investment (TTM) | -- |
| Earning Yield | -- |
| LT Debt / Shareholders Equity | -- |
| Number of Equity Holdings | -- |
Growth Metrics
| EPS Growth (1Y) | -- |
| EPS Growth (3Y) | -- |
| EPS Growth (5Y) | -- |
| Sales Growth (1Y) | -- |
| Sales Growth (3Y) | -- |
| Sales Growth (5Y) | -- |
| Sales per Share Growth (1Y) | -- |
| Sales per Share Growth (3Y) | -- |
| Operating Cash Flow - Growth Rate (3Y) | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Share Classes | |
| LU0037065322 | -- |
| LU0058720904 | -- |
| LU0058721035 | -- |
| LU0097089360 | -- |
| LU0100122521 | -- |
| LU0251853072 | -- |
| LU0251854476 | -- |
| LU0251855366 | -- |
| LU0260062012 | -- |
| LU0260062368 | -- |
| LU0289739699 | -- |
| LU0289740788 | -- |
| LU1808990813 | -- |
| LU1808990904 | -- |
| LU1834054899 | -- |
| LU1934454544 | -- |
| LU1979443824 | -- |
| LU1979444046 | -- |
| LU2080776789 | -- |
| LU2309828486 | -- |
| LU2471913132 | -- |
| LU2485953371 | -- |
| LU2705807340 | -- |
| LU2705807423 | -- |
| LU2705807696 | -- |
| LU2859286135 | -- |
| LU2859286218 | -- |
| LU2859286481 | -- |
| LU2859286564 | -- |
| LU2859286721 | -- |
| LU3035217473 | -- |
| LU3170836533 | -- |
| LU3170836616 | -- |
| LU3170836707 | -- |
| LU3273751217 | -- |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | -- |
| Currency Hedged Fund | -- |
| Socially Responsible Fund | -- |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:LU0260062871", "name") |
| Broad Asset Class: =YCI("M:LU0260062871", "broad_asset_class") |
| Broad Category: =YCI("M:LU0260062871", "broad_category_group") |
| Prospectus Objective: =YCI("M:LU0260062871", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |